Upcoming Event | October 6, 2021 | 12:30 pm & 7:00 pm ET

TREMFYA®: The First and Only Selective IL-23 Inhibitor Approved for Adults With Moderate to Severe Plaque Psoriasis and Adults With Active Psoriatic Arthritis

Presented by Janssen Biotech, Inc. Save your seat for this informative session. Register here.